Catalyst Wire Dossier Catalyst Wire Dossier

Pascolizumab

anti-IL-4 monoclonal antibody
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pascolizumab, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis [Phase 2]

See pricing